glp 1 agonist long term side effects of glp-1 drugs GLP-1 medications, commonly used for type 2 diabetes GLP-1 and GIP-1 receptor agonists
Description
Discontinuation of GLUCAGON-like peptide-1 receptor agonists
doi: 10.1159/000521264 Summary Keywords GLP-1R agonists, obesity, weight-reducing drugs, metabolic diseases, dual agonism Citation Wang J-Y, Wang Q-W, Yang X-Y, Yang W, Li D-R, Jin J-Y, Zhang H-C and Zhang X-F (2023) GLP1 receptor agonists for the treatment of obesity: Role as a promising approach
Hegeds L, Sherman SI, Tuttle RM, et al
2014, Jensen et al
As a weight management drug, it slows down gastric emptying to prolong the feeling of being full and promotes a feeling of satiety in the brain to reduce cravings
